|1.||Bigalke, Boris: 1 article (09/2012)|
|2.||Wurster, Thomas: 1 article (09/2012)|
|3.||Schuster, Andreas: 1 article (09/2012)|
|4.||Stellos, Konstantinos: 1 article (09/2012)|
|5.||Sopova, Kateryna: 1 article (09/2012)|
09/01/2012 - "Other approaches using protease-activated receptor- 1 antagonists vorapaxar or atopaxar, which inhibit the platelet thrombin receptor, soluble GPVI called Revacept©, which blocks the collagen binding sites at the vascular lesion and anopheline saliva protein derived from the malaria vector mosquito, a platelet adhesion inhibitor independent of a GPVI mechanism, still wait for their breakthrough."
|2.||Thrombin Receptors (Thrombin Receptor)